SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eightco Holdings, Inc. is a publicly traded holding company, which operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology, and capital solutions to empower small to medium-sized businesses. It operates through the North America and Europe geographical segments. The company was founded in 1966 and is headquartered in Easton, PA.

Eightco Holdings Inc

Eightco Holdings Inc ($OCTO) experienced extreme volatility, surging thousands of percentage points following news of a significant crypto treasury investment, leading to a frenzy among day traders and short sellers. The community is actively debating whether the massive gains are sustainable, with many pointing to potential dilution and insider selling, while others anticipate a continued squeeze. Speculation is high as traders look for the next stock to replicate $OCTO's meteoric rise, leading to increased attention on other low-float and crypto-related stocks.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

NBIS is trending following a multi-billion dollar agreement with Microsoft to provide AI infrastructure, fueling excitement around the company's growth potential in the AI cloud sector. The community is buzzing about the size and impact of the deal, with some suggesting it could lead to significant revenue growth and new all-time highs. Some analysts see the stock as undervalued given the broader context of increased AI infrastructure spending.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending due to a live demonstration of its solid-state batteries powering a Ducati motorcycle, showcasing faster charging and higher energy density which has sparked optimism about the technology's potential and real-world application. The community is discussing the implications of this milestone, including potential partnerships with major automakers and the possibility of a short squeeze. However, some are cautious, pointing to the long timeline for commercial production and past disappointments.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending due to a proposed $300M private offering of convertible senior notes, announced after a positive earnings call, leading to concerns about dilution and prompting community discussion around the timing and necessity of the offering. While some investors see it as a strategic move for long-term growth and warrant management, others view it as a deceptive practice that takes advantage of retail investors after a strong earnings report. The community is actively debating the implications of the offering, including conversion prices, capped call strikes, and potential impact on share value and future growth prospects.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amidst growing speculation about its spectrum value, particularly after SpaceX's recent spectrum acquisition, and ahead of a potential Apple event where satellite integration could be a talking point. Community discussions revolve around potential bidding wars for Globalstar's spectrum and the company's improving financials. Bullish sentiment is fueled by hopes for new contracts and partnerships, especially with major players like Walmart and government entities, and the potential impact of the new satellite constellation.

Sentage Holdings, Inc. engages in the financial services, which offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China. The company was founded on September 16, 2019 and is headquartered in Shanghai, China.

Sentage Holdings Inc - Ordinary Shares - Class A

Sentage Holdings Inc

Sentage Holdings Inc is trending due to speculative interest, drawing comparisons to recent high-flying low floaters like $OCTO and $MGIH. Community chatter suggests anticipation for a potential short squeeze and after-hours momentum. Some traders are also noting the stock's low float and potential for significant price movement, while others caution about its fundamentals.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

CASY is trending as investors discuss the potential impact of upcoming earnings on the stock's trajectory, with community members debating whether it will be a bull trap or a sustained rally. The stock's valuation and recent performance are key points of contention, as some question whether it is overvalued, while others highlight its growth potential and dividend increases. Community members are also sharing information regarding recent news, analyst ratings, and historical performance.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

ROOT is trending as traders discuss a potential breakout, fueled by recent earnings and revenue numbers despite some ongoing concerns around profitability. The community is weighing the impact of expiring warrants and speculating about potential catalysts, including a short squeeze. Some are drawing comparisons to other insurance companies and the company's relatively low market cap.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid community discussions around the release of documents related to Jeffrey Epstein and their potential implications for prominent figures, including Donald Trump. Sentiment appears divided, with some users expressing concern and others dismissing the relevance of the news. The stock's movement is also being attributed to broader market trends and upcoming economic data.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming burns, staking app launch, and new contests, fueling excitement. Chatter revolves around the strong community, often referred to as "chads", and the project's commitment to a long-term vision. The focus remains on community growth, with members highlighting the coin's organic rise and commitment to future utilities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viking Therapeutics Loses 20% in a Month: How to Play the Stock

VKTX stock slumps after mixed obesity pill study results raise safety concerns and highlight fierce market competition.

NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?

Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study.

Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights

Viking Therapeutics, Inc. (VKTX) reached $27.05 at the closing of the latest trading day, reflecting a -1.92% change compared to its last close.

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet?

NVO and VKTX face setbacks and rising competition as they battle for ground in the GLP-1 obesity market.

Does Lilly's New Obesity Pill Data Put It Back in the Weight Game?

LLY's obesity pill orforglipron hits weight-loss and A1C goals in a phase III trial, lifting shares nearly 6% and reviving investor confidence.

Can Novo Nordisk Offset GLP-1 Pressures With Rare Disease Wins?

NVO faces slowing GLP-1 momentum but leans on rare disease wins and new Wegovy approval to bolster growth.

Viking Therapeutics&nbsp;reportedly saw short interest jump from 26.4% to 30.8% last week, the highest since early 2020.Days-to-cover rose from 10.2 to 11.1, even with heavy volumes.&nbsp;<a href="https://stocktwits.com/symbol/VKTX">Viking’s stock</a>, which had more than doubled from April lows ahead of the data, fell nearly 45% intraday Tuesday and ended the week down 36%, leaving it 35% lower year-to-date, according to Ortex data compiled by The Fly.&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vktx-stock-in-spotlight-on-high-dropout-rate-in-oral-weight-loss-drug-study/chsgSlCRdgY">Topline Phase 2 data</a> from the 280-patient Venture-Oral trial showed&nbsp;that once-daily VK2735 tablets achieved&nbsp;a mean weight loss of up to 12.2% at 13 weeks&nbsp;compared to placebo, with early statistical significance observed at higher doses and no plateau effect.&nbsp;A maintenance cohort suggested rapid weight loss induction followed by continued reductions at lower doses, supporting a potential commercial angle.&nbsp;However, discontinuation rates reached 28%, compared with 18% for the placebo, mostly&nbsp;due to gastrointestinal-related adverse events, which investors judged more troubling&nbsp;than those observed in Phase 1.&nbsp;Viking noted most events were mild or moderate and emphasized&nbsp;the development of both oral and injectable formulations.<a href="https://stocktwits.com/news-articles/markets/equity/wall-street-defends-viking-weight-loss-pill-trial-stock-rout-retail-selloff-unjustified/chsiBEJRdWL">Analysts broadly defended the company</a>. Leerink called the selloff “overdone,” Jefferies noted that investors were underappreciating dosing optimization, Stifel highlighted VK2735’s potency and flexibility&nbsp;compared to peers, and H.C. Wainwright described the weight-loss profile as “encouraging” despite tolerability concerns.&nbsp;All reiterated ‘Buy’ or ‘Outperform’ ratings, with targets ranging from $95 to $118.On Stocktwits, retail sentiment for Viking was ‘extremely bullish’ amid ‘extremely high’ message volume.One user suggested the company could quickly regain momentum with a big-pharma partnership and several new trial starts, arguing that gastrointestinal side effects are a known feature of GLP-1 drugs and that future studies may demonstrate improved tolerability.&nbsp;In their view, Viking’s long-term story is intact, with the upcoming subcutaneous Phase 3 trial seen as the main driver if no deal materializes.<stembedurl>https://stocktwits.com/saifnila2/message/626380440</stembedurl>Others emphasized that Viking risks losing investor confidence if it does not provide a more transparent and scientifically detailed explanation of the Phase 2 results.&nbsp;They argued that prolonged short selling thrives on silence and that additional analyses highlighting efficacy signals would help restore sentiment and reframe the narrative.<stembedurl>https://stocktwits.com/NMKW/message/626373166</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Viking Therapeutics, Inc., in front of a screen showing the company's latest stock market chart on July 19, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Viking Short Interest Hits 5-Year High After Weight-Loss Drug Stumble, But Retail Clings To Bullish Mood For Now

The stock plunged last week after Phase 2 obesity drug results showed strong weight loss but higher discontinuation rates due to side effects, despite analysts' continued bullish views.

Equity

Viking Therapeutics (VKTX) Down 23.4% Since Last Earnings Report: Can It Rebound?

Viking Therapeutics (VKTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?

Lilly's obesity pill orforglipron disappointed with lower weight loss, but its broad late-stage pipeline keeps growth hopes alive.

Post Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock?

Viking Therapeutics stock sinks after mixed results from its obesity pill trial, raising doubts over safety, tolerability and future prospects.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

VKTX
Viking Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VKTX News

VKTX Viking Therapeutics Inc